1.Acquired Hemophilia A Combined with Systemic Lupus Erythematosus: A Case Report and Literature Review.
Juyoung YOU ; Hojae KIM ; Jin Su PARK ; Myung Hee CHANG ; Chan Hee LEE
Journal of Rheumatic Diseases 2017;24(5):309-312
Acquired hemophilia A (AHA) is a rare hemorrhagic disorder caused by autoantibodies against factor VIII (FVIII). An 80-year-old woman presented multiple bruises on her upper and lower extremities, along with gross hematuria. Extensive ecchymosis and swelling were observed on the buttocks. She had anemia and normal platelet count. The initial coagulation results showed prolonged activated partial thromboplastin time (aPTT, 68.5 seconds) and normal prothrombin time. According to the mixing test, we observed a decreased FVIII activity (2%), increased factor VIII inhibitor (FVIII-I) titer (74.4 BU), and negative lupus anticoagulant. AHA was diagnosed based on late onset bleeding and increased FVIII-I titer. Additionally, she met the criteria for systemic lupus erythematosus (oral ulcer, photosensitivity, renal disorder, and positivity for antinuclear and anti-β2-glycoprotein-I antibodies). She was started on oral prednisolone for FVIII-I eradication. Post-treatment, her bleeding tendency, aPTT (47.3 seconds), and FVIII-I titer decreased (1.24 BU), and FVIII activity increased (10%).
Aged, 80 and over
;
Anemia
;
Autoantibodies
;
Buttocks
;
Contusions
;
Ecchymosis
;
Factor VIII
;
Female
;
Hematuria
;
Hemophilia A*
;
Hemorrhage
;
Hemorrhagic Disorders
;
Humans
;
Lower Extremity
;
Lupus Coagulation Inhibitor
;
Lupus Erythematosus, Systemic*
;
Partial Thromboplastin Time
;
Platelet Count
;
Prednisolone
;
Prothrombin Time
;
Ulcer
2.Comparison of tooth movement and biological response in corticotomy and micro-osteoperforation in rabbits
Junghan KIM ; Yoon Ah KOOK ; Mohamed BAYOME ; Jae Hyun PARK ; Won LEE ; Hojae CHOI ; Noha H ABBAS
The Korean Journal of Orthodontics 2019;49(4):205-213
OBJECTIVE:
The aim of this study was to evaluate the amount of tooth movement and histologic changes with different corticotomy designs and micro-osteoperforation in rabbits.
METHODS:
The sample consisted of 24 rabbits divided into three experimental groups (triangular corticotomy [TC] and indentation corticotomy [IC] with flap, and flapless micro-osteoperforations [MP]) and a control. A traction force of 100 cN was applied by connecting the first premolars to the incisors. The amount of tooth movement was measured. Kruskal-Wallis test was used to assess differences in tooth movement between the groups. Micro-computed tomography, hematoxylin and eosin staining, and tartrate-resistant acidic phosphatase (TRAP) analysis were performed. Analysis of variance was applied to assess differences in TRAP-positive osteoclast count between the groups.
RESULTS:
The amount of tooth movement increased by 46.5% and 32.0% in the IC and MP groups, respectively, while the bone fraction analysis showed 69.7% and 8.5% less mineralization compared to the control. There were no significant intergroup differences in the number of TRAP-positive osteoclasts.
CONCLUSIONS
The micro-osteoperforation group showed no significant differences in the amount of tooth movement compared to the corticotomy groups, nor in the TRAP-positive osteoclast count compared to both corticotomy groups and control.
3.Lateral Cephalometric Measurements of Class I Malocclusion Patients with Uncertainty
Ji Min LEE ; Ji Soo SONG ; Hong Keun HYUN ; Young Jae KIM ; Jung Wook KIM ; Ki Taeg JANG ; Sang Hoon LEE ; Hojae KIM ; Hyo Min CHO ; Teo Jeon SHIN
Journal of Korean Academy of Pediatric Dentistry 2018;45(1):65-74
The aim of this study was to obtain the traceability of the software used to analyze lateral cephalometry and to calculate the uncertainty of the measurements. Furthermore, this study aimed to provide a basis for obtaining standard references for measurement values for orthodontic treatment in children.Cephalometric data were collected from 100 children diagnosed with class I malocclusion between the ages 6 to 13 years who visited the pediatric dentist at Seoul National University Dental Hospital. To ensure traceability, a phantom device was created. Correction values were calculated by measuring the length and angle of the phantom device using the software. Type A uncertainty was calculated by obtaining the standard deviation of cephalometric measurements of 100 persons and the standard error of repeated measurements. Determination of the type B uncertainty was induced by minimum resolution and the position of the head. Using these, the combined standard uncertainty was obtained and the expanded uncertainty was calculated.The results of this study confirm that the currently used software has high accuracy and reliability. Furthermore, the uncertainty of orthodontic measurements in Korean children aged 6 to 13 years was calculated, and distribution range for class I malocclusion with 95% confidence interval was suggested.
Cephalometry
;
Child
;
Dentists
;
Head
;
Humans
;
Malocclusion
;
Seoul
;
Uncertainty
4.Alterations and Co-Occurrence of C-MYC, N-MYC, and L-MYC Expression are Related to Clinical Outcomes in Various Cancers
Moonjung LEE ; Jaekwon SEOK ; Subbroto Kumar SAHA ; Sungha CHO ; Yeojin JEONG ; Minchan GIL ; Aram KIM ; Ha Youn SHIN ; Hojae BAE ; Jeong Tae DO ; Young Bong KIM ; Ssang-Goo CHO
International Journal of Stem Cells 2023;16(2):215-233
Background and Objectives:
MYC, also known as an oncogenic reprogramming factor, is a multifunctional transcription factor that maintains induced pluripotent stem cells (iPSCs). Although MYC is frequently upregulated in various cancers and is correlated with a poor prognosis, MYC is downregulated and correlated with a good prognosis in lung adenocarcinoma. MYC and two other MYC family genes, MYCN and MYCL, have similar structures and could contribute to tumorigenic conversion both in vitro and in vivo.
Methods:
and Results: We systematically investigated whether MYC family genes act as prognostic factors in various human cancers. We first evaluated alterations in the expression of MYC family genes in various cancers using the Oncomine and The Cancer Genome Atlas (TCGA) database and their mutation and copy number alterations using the TCGA database with cBioPortal. Then, we investigated the association between the expression of MYC family genes and the prognosis of cancer patients using various prognosis databases. Multivariate analysis also confirmed that co-expression of MYC/MYCL/MYCN was significantly associated with the prognosis of lung, gastric, liver, and breast cancers.
Conclusions
Taken together, our results demonstrate that the MYC family can function not only as an oncogene but also as a tumor suppressor gene in various cancers, which could be used to develop a novel approach to cancer treatment.